Abstract
This review article describes the current TB drugs, their merits and demerits as well as the new promising anti- TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.
Keywords: Tuberculosis, Mycobacterium tuberculosis, anti-tubercular drugs, drug targets, structure-activity relationship
Mini-Reviews in Medicinal Chemistry
Title: Recent Developments in Antitubercular Drugs
Volume: 8 Issue: 14
Author(s): Pallavi Ahirrao
Affiliation:
Keywords: Tuberculosis, Mycobacterium tuberculosis, anti-tubercular drugs, drug targets, structure-activity relationship
Abstract: This review article describes the current TB drugs, their merits and demerits as well as the new promising anti- TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.
Export Options
About this article
Cite this article as:
Ahirrao Pallavi, Recent Developments in Antitubercular Drugs, Mini-Reviews in Medicinal Chemistry 2008; 8 (14) . https://dx.doi.org/10.2174/138955708786786516
DOI https://dx.doi.org/10.2174/138955708786786516 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Insights into the Diagnosis and Chemotheraphy for Visceral Leishmaniasis
Current Drug Delivery The Methylerythritol Phosphate Pathway and its Significance as a Novel Drug Target
Current Pharmaceutical Biotechnology Synthetic Versus Enzymatic Pictet-Spengler Reaction: An Overview
Current Organic Synthesis Antimicrobial Activity of Synthesized 2-Methylthiobenzo[g][1,2,4]- triazolo[1,5-a]quinazoline Derivatives
Medicinal Chemistry Piperidin-4-one: The Potential Pharmacophore
Mini-Reviews in Medicinal Chemistry Critical Parameters for Genome Editing Using Zinc Finger Nucleases
Mini-Reviews in Medicinal Chemistry Eradicating Bacterial Biofilms with Natural Products and their Inspired Analogues that Operate Through Unique Mechanisms
Current Topics in Medicinal Chemistry Xenicane Natural Products: Biological Activity and Total Synthesis
Current Pharmaceutical Design Synthesis, In vitro and In silico Studies of Benzothiazole Azo-Ester Derivatives as Anti-TB Agents
Anti-Infective Agents Applications of Biophysical Tools to Target-Based Discovery of Novel Antibacterial Leads
Current Drug Targets Vertebral Lesions from AIDS-Related Kaposi's Sarcoma
Current HIV Research Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment
Current Topics in Medicinal Chemistry Alkaptonuria, Ochronosis and Ochronotic Arthropathy in Mainland France and the Reunion Island. A Report of Clinical and Molecular Findings in 29 Patients
Current Rheumatology Reviews Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Current Medicinal Chemistry Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis
Current Pharmaceutical Design New Approved Medications for Idiopathic Pulmonary Fibrosis
Current Drug Therapy The Antibiotic Effects of Vitamin D
Endocrine, Metabolic & Immune Disorders - Drug Targets Developing Country Applications of Molecular Farming: Case Studies in South Africa and Argentina
Current Pharmaceutical Design